Skip to main content
. 2018 May 4;9:417. doi: 10.3389/fphar.2018.00417

Table 1.

Modulators of the TLR2/1 signaling pathway.

Inhibitor Target References
MicroRNAs
miR-UL112-3p TLR2 Vo et al., 2005
miR-K5 IRAK1 Xiao and Rajewsky, 2009
miR-K9 MyD88 Xiao and Rajewsky, 2009
miR-143 TLR2 and NF-κB Krichevsky et al., 2003; Wayman et al., 2008
miR-132 IRAK4 Abend et al., 2012
miR-21 MyD88 and IRAK1 O'Neill et al., 2011
miR-146a TRAF6 and IRAK1 Chen et al., 2013a; Guo et al., 2013; Landais et al., 2015; Liu et al., 2015
miR-124 TRAF6 Taganov et al., 2006; Nahid et al., 2013
miR-92a MKK4 Meisgen et al., 2014
miR-147 miR-7116-5p Unknown TNFα Saba et al., 2012; Ma et al., 2014; Santra et al., 2014
miR-155 SOCS1 and SHIP1 Liu et al., 2009; Zhang et al., 2016
NATURAL COMPOUNDS
Methylpenicinoline Unknown Strassheim et al., 2005
Calcitriol miR-155 Nakagawa et al., 2002
Schizandrin A/B Unknown Aravalli et al., 2008; Aslanidis et al., 2015; Koymans et al., 2015
Gomosins A/G/J/N Pristimerin Nrf2 IRAK1 and TRAF6 Chen et al., 2013b; Kim et al., 2014
Deoxysappone B Unknown Song et al., 2016
Sparstolonin B MyD88 Park et al., 2014
Daphnetin A20 Kumar et al., 2016
Curcurbitacin B/E/I Nrf2 Liu et al., 2016
Kolaviron Nrf2 Yao et al., 2011
Pseudoginsenoside-F11 MyD88 Park et al., 2015
SYNTHETIC COMPOUNDS
CU-CPT22 TLR2/1 Arel-Dubeau et al., 2015; Olajide et al., 2017
RSCL-0409 MyD88 Oyagbemi et al., 2017
C16H15NO4 (C29) MyD88 Wang et al., 2014
Ortho-vanillin MyD88 Wang et al., 2014
M2000 Unknown Kalluri et al., 2010; Mistry et al., 2015
G2013 Unknown/Tollip Afraei et al., 2015; Mirshafiey et al., 2016; Aletaha et al., 2017
NG25 TAK1 Pourgholi et al., 2017
MRT67307 TBK1 and IKKε Jahromi et al., 2017
BMS345541 IKKβ Nazeri et al., 2017
MCAP Unknown Hajivalili et al., 2016
Bay-11-708 NF-κB Sharifi et al., 2017
Candesartan Angiotensin II receptor Pauls et al., 2012
Fasudil Rho kinase Yang et al., 2006; Clark et al., 2011
cRGD MFG-E8 receptor Matteucci et al., 2015